HK1163524A1 - 胰腺腫瘤治療 - Google Patents
胰腺腫瘤治療Info
- Publication number
- HK1163524A1 HK1163524A1 HK12104142.5A HK12104142A HK1163524A1 HK 1163524 A1 HK1163524 A1 HK 1163524A1 HK 12104142 A HK12104142 A HK 12104142A HK 1163524 A1 HK1163524 A1 HK 1163524A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tumour treatment
- pancreatic tumour
- pancreatic
- treatment
- tumour
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08170537 | 2008-12-02 | ||
PCT/EP2009/065857 WO2010063630A2 (en) | 2008-12-02 | 2009-11-25 | Pancreatic tumour treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1163524A1 true HK1163524A1 (zh) | 2012-09-14 |
Family
ID=40445618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12104142.5A HK1163524A1 (zh) | 2008-12-02 | 2012-04-26 | 胰腺腫瘤治療 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20110293672A1 (zh) |
EP (2) | EP3181123A1 (zh) |
JP (2) | JP2012510489A (zh) |
CN (3) | CN104382862A (zh) |
AU (1) | AU2009321621B2 (zh) |
CA (1) | CA2745238A1 (zh) |
HK (1) | HK1163524A1 (zh) |
WO (1) | WO2010063630A2 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2891485B1 (en) * | 2012-08-31 | 2018-12-26 | Chung-Ang University Industry Academic Cooperation Foundation | Method for preparing microspheres for emboli, and method for preparing microspheres to which drug-containing carrier is bound |
CA2923741C (en) | 2013-09-19 | 2022-06-07 | Microvention, Inc. | Polymer films |
BR112016005770B1 (pt) | 2013-09-19 | 2021-07-27 | Terumo Corporation | Partículas de polímero |
KR102287781B1 (ko) | 2013-11-08 | 2021-08-06 | 테루모 가부시키가이샤 | 중합체 입자 |
US9907880B2 (en) | 2015-03-26 | 2018-03-06 | Microvention, Inc. | Particles |
EP3302423B1 (en) | 2015-06-04 | 2022-05-25 | Crititech, Inc. | Particle production system and particle collection device |
KR102490665B1 (ko) | 2016-04-04 | 2023-01-27 | 크리티테크, 인크. | 고형 종양의 치료 방법 |
CA3038642C (en) | 2016-09-28 | 2021-11-02 | Terumo Corporation | Polymer particles comprising polymerizable pharmaceutical agents |
WO2018227037A1 (en) * | 2017-06-09 | 2018-12-13 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
CN115919815A (zh) | 2017-06-14 | 2023-04-07 | 克里蒂泰克公司 | 治疗肺部疾病的方法 |
SG11202001802YA (en) | 2017-10-03 | 2020-03-30 | Crititech Inc | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4224427A (en) | 1978-06-01 | 1980-09-23 | Ciba-Geigy Corporation | Process for preparing hydrogels as spherical beads of large size |
US4978713A (en) | 1987-12-16 | 1990-12-18 | Ciba-Geigy Corporation | Polyvinyl alcohol derivatives containing pendant vinylic monomer reaction product units bound through ether groups and hydrogel contact lenses made therefrom |
GB9023498D0 (en) | 1990-10-29 | 1990-12-12 | Biocompatibles Ltd | Soft contact lens material |
GB9301702D0 (en) | 1993-01-28 | 1993-03-17 | Biocompatibles Ltd | New materials |
GB9301701D0 (en) | 1993-01-28 | 1993-03-17 | Biocompatibles Ltd | New zwitterionic materials |
TW272976B (zh) | 1993-08-06 | 1996-03-21 | Ciba Geigy Ag | |
GB9415926D0 (en) | 1994-08-04 | 1994-09-28 | Biocompatibles Ltd | New materials |
US20030129215A1 (en) | 1998-09-24 | 2003-07-10 | T-Ram, Inc. | Medical devices containing rapamycin analogs |
WO2000029481A1 (en) | 1998-11-13 | 2000-05-25 | Biocompatibles Limited | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
UA77200C2 (en) * | 2001-08-07 | 2006-11-15 | Wyeth Corp | Antineoplastic combination of cci-779 and bkb-569 |
US7547673B2 (en) * | 2001-09-13 | 2009-06-16 | The Johns Hopkins University | Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production |
US7094369B2 (en) * | 2002-03-29 | 2006-08-22 | Scimed Life Systems, Inc. | Processes for manufacturing polymeric microspheres |
KR101157260B1 (ko) * | 2003-02-12 | 2012-06-15 | 바이오컴페터블즈 유케이 리미티드 | 고형 종양의 화학색전술용 조성물 |
CN106344968B (zh) * | 2003-02-12 | 2019-09-24 | 生物相容英国有限公司 | 组合物在制备用于在实体瘤的患者进行栓塞治疗中在循环系统中形成栓塞的药物中的用途 |
US20040161466A1 (en) * | 2003-02-14 | 2004-08-19 | Biocompatibles Uk Limited | Chemoembolisation |
EP1687032B1 (en) * | 2003-11-14 | 2010-02-24 | Genvec, Inc. | Pharmaceutical composition for treating unresectable, locally advanced pancreatic cancer (lapc). |
WO2005087193A2 (en) * | 2004-03-11 | 2005-09-22 | Biocompatibles Uk Limited | Chemoembolisation involving an anthracycline compound |
EP3085361A1 (en) * | 2004-09-07 | 2016-10-26 | Biocompatibles UK Limited | Compositions comprising camptothecins in microspheres |
WO2007090897A1 (en) | 2006-02-10 | 2007-08-16 | Biocompatibles Uk Limited | Loading of hydrophobic drugs into hydrophilic polymer delivery systems |
PT2034951E (pt) * | 2006-06-22 | 2013-04-18 | Biocompatibles Uk Ltd | Produto farmacêutico reidratável |
EP1985286A1 (en) * | 2007-04-24 | 2008-10-29 | Biocompatibles UK Limited | Microspheres for treatment of brain tumours |
-
2009
- 2009-11-25 WO PCT/EP2009/065857 patent/WO2010063630A2/en active Application Filing
- 2009-11-25 CN CN201410670948.8A patent/CN104382862A/zh active Pending
- 2009-11-25 EP EP17155346.4A patent/EP3181123A1/en not_active Withdrawn
- 2009-11-25 JP JP2011538957A patent/JP2012510489A/ja active Pending
- 2009-11-25 CA CA2745238A patent/CA2745238A1/en not_active Abandoned
- 2009-11-25 EP EP09793490.5A patent/EP2367535B1/en not_active Not-in-force
- 2009-11-25 US US13/132,259 patent/US20110293672A1/en not_active Abandoned
- 2009-11-25 CN CN201610404188.5A patent/CN105999297A/zh active Pending
- 2009-11-25 CN CN200980155864.8A patent/CN102300560B/zh not_active Expired - Fee Related
- 2009-11-25 AU AU2009321621A patent/AU2009321621B2/en not_active Ceased
-
2012
- 2012-04-26 HK HK12104142.5A patent/HK1163524A1/zh not_active IP Right Cessation
-
2014
- 2014-06-04 JP JP2014116001A patent/JP5960751B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP3181123A1 (en) | 2017-06-21 |
WO2010063630A2 (en) | 2010-06-10 |
CN104382862A (zh) | 2015-03-04 |
JP2012510489A (ja) | 2012-05-10 |
WO2010063630A3 (en) | 2010-12-23 |
CN105999297A (zh) | 2016-10-12 |
EP2367535B1 (en) | 2017-02-22 |
CN102300560B (zh) | 2016-09-07 |
JP2014208661A (ja) | 2014-11-06 |
JP5960751B2 (ja) | 2016-08-02 |
AU2009321621B2 (en) | 2013-06-13 |
EP2367535A2 (en) | 2011-09-28 |
CA2745238A1 (en) | 2010-06-10 |
AU2009321621A1 (en) | 2010-06-10 |
CN102300560A (zh) | 2011-12-28 |
US20110293672A1 (en) | 2011-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1175476A1 (zh) | 癌症治療 | |
GB0802116D0 (en) | Treatment | |
IL213619A0 (en) | Treatment | |
EP2322076A4 (en) | ENDOSCOPE OF TREATMENT | |
HK1163524A1 (zh) | 胰腺腫瘤治療 | |
IL206654A0 (en) | Combination therapy | |
EP2310006A4 (en) | TREATMENT OF CANCER | |
IL208354A0 (en) | Methods of treatment | |
ZA201205004B (en) | Methods for treating pancreatic cancer | |
GB0822011D0 (en) | Treatment | |
GB0816399D0 (en) | Irradiation treatment | |
IL213761A0 (en) | Novel ortho-aminoamides for the treatment of cancer | |
GB0817067D0 (en) | Intestinal treatment | |
GB0811992D0 (en) | Treatment | |
GB0804496D0 (en) | Treating cancer | |
GB0900599D0 (en) | Treatment | |
IL210066A0 (en) | Novel ortho-aminoanilides for the treatment of cancer | |
IL215037A0 (en) | Treatment of pancreatic cancer | |
GB201013898D0 (en) | Well treatment | |
EP2164494A4 (en) | Methods of Treatment | |
GB0723100D0 (en) | Treatment of HFnEF | |
GB201001521D0 (en) | Treatment | |
GB0820972D0 (en) | Treatment | |
GB0913968D0 (en) | Treatment | |
GB0803948D0 (en) | Combination therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20201125 |